12:00 AM
Mar 13, 2000
 |  BC Week In Review  |  Company News  |  Other News

Pharmasset other research news

Pharmasset received a $100,000 Phase I SBIR grant from the National Cancer Institute to develop inhibitors...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >